: Clinical research is going digital.

We’ll make sure it’s safe and sound.

5 min readAug 10, 2021

Introduce

I firmly believe that if people are using the normal financial services within the world, they are doing not fully understand its nature. I don’t want to criticize or mess things up with it but there is obvious inconveniences still exist and there’s not really an honest solution to the present. It is also possible that a lot of people noticed the matter of the above example that built the Blockchain. Towards a transparency and decentralization for users within the future. It is clear that Blockchain is asserting tons useful when using it for the planet economy. Although still very small compared to other markets within the world, the cryptocurrency market of Blockchain products is showing no small attraction. As more projects keep building on different smart chains, there is a need for interoperability between this different blockchains, users want to enjoy the features of trading two assets that are not on the same blockchain network, without having to forfeit their very essence of using cryptocurrency in the first place, Triall is laying the groundwork for tomorrow’s digital playing field in clinical trials.

About

Triall is laying the groundwork for tomorrow’s digital playing field in clinical trials. They bring Web 3.0 to medical research by developing a digital ecosystem of blockchain-integrated software solutions. Their blockchain infrastructure makes medical data tamper-resistant. It also enables secure and efficient connections between the many isolated systems and parties involved in clinical research.

Their mission is to accelerate the introduction of safe and affordable vaccines and therapeutics into society by streamlining clinical trials:
1. Deep Industry Experience: Combined, our team has managed 100+ clinical trials across 30+ countries, and successfully grown companies both in the Life Sciences and Software/Blockchain-as-a-Service industries.

2. Thought Leaders: Their team has published 250+ peer-reviewed papers on innovation in medical research, featured in top-tier scientific journals such as Nature and Science.

3. Global Partner & Customer Network: Years of industry operations have gained us a strong value network of partners and potential customers that stretches the globe.

4. Double-Digit Growth: Their target market is characterized by rapid digitalization, decentralization, and double-digit growth (CAGR of 13.8%). High upside is projected for those that can underpin this emerging digital ecosystem. Their solutions are specifically designed to do so.

5. Working Product: Their first product Verial eTMF is in production and currently being onboarded by 6 commercial clinical trial projects across 3 countries, involving an approximate total of 2500 participants. More projects are lined up.

6. Market Validation: Leading stakeholders in their customer domain have expressed interest in our first products, which directly respond to actual customer pain points.

Core Solutions:

Verial eTMFClinical document management application with blockchain proofs of data integrity and authenticity.

Triall CTMSLightweight trial management dashboard with blockchain API-driven data integration.

Atena PRMVendor selection and management platform with blockchain proofs of fair tender and bidding processes

DETAILS & ALLOCATION: Token Triall PRE-SALE

Triall will offer 52% of the total TRL token supply to the community through its Initial Token Offering (ITO) and through the Triall Community Fund. This ITO serves to distribute early access to the Triall ecosystem and will support in funding its development. TRL tokens are issued using the ERC-20 standard on Ethereum and are available for anyone meeting our legal requirements.

Token allocation

Triall Community Fund (TCF)
To further engage the community in the development of the Triall ecosystem, 10% of the total TRL token supply is reserved for the Triall Community Fund (TCF). The TCF is established to help the Triall ecosystem grow globally through community-sponsored projects and initiatives. Examples of such projects may include a TRL (mobile) wallet, applications, token integration with other networks, marketing campaigns, websites promoting Triall, bounty programs, and competitions, or any other initiative that reaches a majority vote. After the initial pool of 10% of TRL tokens has been depleted, part of the sustainable operating income from Triall may be reinvested into the TCF.

TRL value drivers

Triall will pursue the listing of TRL on a growing number of crypto exchanges to promote the liquidity of our main utility token. As a publicly tradeable token, the value of TRL will be determined by market supply and demand. Therefore, the token economics of TRL are designed to limit supply and drive demand. The figure below gives an overview of the main value drivers of TRL.

The supply of TRL is limited by reducing the total circulating supply through various token lock-up mechanics. In addition, our tokenized SaaS subscription model provides additional stability as TRL tokens are removed from circulation each time a new client is onboarded. Moreover, our conversion mechanism and token burn policy stimulate a deflationary trend where the total TRL token supply is expected to decrease over time, creating additional upward pressure on the demand.

The demand for TRL is driven by increasing the utility and boosting the adoption of the ecosystem. Over the course of developing the Triall ecosystem, we expect to see a strong increase in TRL token utility and market demand driven by the growth of the ecosystem (and associated network effects). To this end, our team’s core focus is the successful release and commercialization of a growing number of Triall solutions.

BACKED BY

Conclusion

The application of Blockchain technology in many industries is becoming more popular. Their modular but complementary eClinical solutions are all designed to greatly improve data integrity, auditability, and task efficiency in modern-day medical research processes. These functionalities answer to growing calls for data security and traceability by industry regulators across the globe.